Agenda

*topics subject to change prior to date of event

7:00 am REGISTRATION, EXHIBITS AND BREAKFAST
7:15 am BREAKFAST: PRODUCT THEATER: **
Redefining Approaches in Early-Line Multiple Myeloma Treatment

William Bensinger, M.D., Swedish Cancer Institute
8:00 am WELCOME AND INTRODUCTION
Elias Anaissie, M.D., Medical Director CTI Clinical Trial & Consulting; Program Director
8:10 am HEMATOLOGIC MALIGNANCIES IN THE 21st CENTURY: LESSONS LEARNED AND FUTURE INSIGHTS
Charles A. Schiffer, M.D.
8:40 am CHRONIC LYMPHOCYTIC LEUKEMIA: STATE OF THE ART UPDATE
Susan O’Brien, M.D.
9:10 am CURRENT AND EMERGING THERAPIES FOR MYELODYSPLASTIC SYNDROMES
Rami S. Komrokji, MBBS, M.D.
9:40 am PANEL DISCUSSION
9:50 am BREAK
10:00 am KEYNOTE: ACUTE LYMPHOBLASTIC LEUKEMIA: STATE OF THE ART
Hagop M. Kantarjian, M.D.
10:45 am KEYNOTE: IMPROVING OUTCOMES IN HIGH-RISK ACUTE MYELOGENOUS LEUKEMIA
Hagop M. Kantarjian, M.D.
11:30 am CHRONIC MYELOGENOUS LEUKEMIA: A 2020 UPDATE
Jorge E. Cortes, M.D.
12:00 pm PANEL DISCUSSION
12:15 pm DISMISS FOR LUNCH
12:30 pm LUNCH: PRODUCT THEATER: **
CLL Updates

Ryan Jacobs, M.D., Levine Cancer Institute
1:15 pm IMMUNOTHERAPY FOR HEMATOLOGIC MALIGNANCIES: CAR-Ts AND BEYOND
Jacalyn Rosenblatt, M.D.
1:45 pm TREATMENT OF RELAPSED HODGKIN LYMPHOMA
Stephen M. Ansell, M.D., Ph.D.
2:15 pm AGGRESSIVE NON-HODGKIN LYMPHOMAS: TREATMENT OF NEWLY DIAGNOSED AND RELAPSED DISEASE
Julie M. Vose, M.D., MBA
2:45 pm PANEL DISCUSSION
3:00 pm BREAK
3:15 pm UPDATES IN THROMBOCYTOPENIA DISORDERS
Marshall Mazepa, M.D.
3:45 pm HOW I TREAT PERSISTENT REFRACTORY MULTIPLE MYELOMA
Robert Z. Orlowski, M.D., PhD
Chair Ad Interim, Department of Lymphoma / Myeloma and Director of the Myeloma Section
MD Anderson Cancer Center
4:15 pm PANEL DISCUSSION
4:25 pm CLOSING REMARKS
James Essell, M.D., Medical Director Blood Cancer Center, Program Co-Director
4:30 pm DISMISS

** Non-CME Educational Activities: All events are scheduled during times that do not conflict with Symposium CME Educational Programming. These optional non-CME educational activities are not approved for CME or continuing education Credit. The content and opinions of these optional non-CME activities are those of the sponsor or presenters.